Main navigation
- Home
- About us
- Medicines
- Research
- Careers
- Responsibility
- Strategy and vision
- Patient safety
- Product counterfeiting
- Access to medicines
- In the developing world
- Sales & marketing
- Research ethics
- Clinical trials
- Our employees
- Community support
- Climate change
- Sustainable production
- Pharmaceuticals in the environment
- Working with suppliers
- Management & measurement
- Code, policies & standards
- Reporting performance
- Partnering
- Media
- Investors
You are here
- Home
- Responsibility
- Research ethics
- Animal research
Animal research
- Introduction
- Responsible use
- High standards of care
- Non-Human primate research
- Stakeholder engagement
- Global Improvement Plan
- Driving best practice in 3Rs – A new global award
- Other examples of our commitment to the 3Rs
- Protests
Introduction
-
- Animal studies continue to play a vital role in the research and development of new and improved medicines.
- We are committed to the responsible use of animals and the welfare of the animals we use is a top priority.
The content of this page was externally assured by Bureau Veritas, February 2009
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 06:25 GMT
Detailed share price